Pharmaceutical

The Curious Case of Norelgestromin: A Patch in Time Saves Nine!

Explore the fascinating science and exciting future of Norelgestromin, the progestin hero behind modern contraceptive patches.

CP-39,332: The Little Talked About Substance with Big Implications

CP-39,332 is a compound developed by Pfizer in the 1980s as a potent antidepressant, but despite early promise, it was shelved due to side effects and regulatory challenges. This article delves into its journey and highlights the potential lost through bureaucratic hurdles.

Decoding Neuraminidase: The Enzyme Behind the Flu Battle

Discover the fascinating role of neuraminidase, a key enzyme in influenza's viral life cycle, and how its understanding has transformed our approach to treating flu infections.

Fazamorexant: A Sleep Revolution or Just Dream Dust?

What if falling asleep was as easy as popping a revolutionary pill? Enter fazamorexant, a new sleep aid with a unique method of action promising to redefine how we approach insomnia treatment.